MARKCRISPRプラスミド
サンタクルスバイオテクノロジー社は遺伝子サイレンシング用のCRISPR/Cas9ノックアウト及びCRISPR Double Nickaseプラスミドを含め、広範囲の遺伝子編集製品を提供しております。MARK遺伝子サイレンサーは、MARK CRISPR/Cas9ノックアウトプラスミドとMARKDouble Nickaseプラスミドとして利用可能です。遺伝子活性化用のMARKCRISPR/dCas9 Activationプラスミド及びCRISPR Lenti Activationシステムも利用できます。遺伝子サイレンサーと活性化剤はタンパク質の検出に使用された抗体と組み合わせた遺伝子研究に有用です。
MARK CRISPR Knockout, HDR and Double Nickase Plasmids
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
MARK1 CRISPR/Cas9 KOプラスミド (h) | sc-404508 | h | Gene Knockout | GFP | 0 | ||
MARK1 HDRプラスミド (h) | sc-404508-HDR | h | Homology Directed Repair | Puromycin | 0 | ||
MARK1 Double Nickaseプラスミド (h) | sc-404508-NIC | h | Gene Knockout | Puromycin | 0 | ||
MARK1 Double Nickaseプラスミド (h2) | sc-404508-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
MARK1 CRISPR/Cas9 KOプラスミド (m) | sc-432657 | m | Gene Knockout | GFP | 0 | ||
MARK1 HDRプラスミド (m) | sc-432657-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
MARK1 Double Nickaseプラスミド (m) | sc-432657-NIC | m | Gene Knockout | Puromycin | 0 | ||
MARK1 Double Nickaseプラスミド (m2) | sc-432657-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
MARK2 CRISPR/Cas9 KOプラスミド (h) | sc-403714 | h | Gene Knockout | GFP | 1 | ||
MARK2 HDRプラスミド (h) | sc-403714-HDR | h | Homology Directed Repair | Puromycin | 1 | ||
MARK2 Double Nickaseプラスミド (h) | sc-403714-NIC | h | Gene Knockout | Puromycin | 1 | ||
MARK2 Double Nickaseプラスミド (h2) | sc-403714-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
MARK2 CRISPR/Cas9 KOプラスミド (m) | sc-420164 | m | Gene Knockout | GFP | 0 | ||
MARK2 HDRプラスミド (m) | sc-420164-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
MARK2 Double Nickaseプラスミド (m) | sc-420164-NIC | m | Gene Knockout | Puromycin | 0 | ||
MARK2 Double Nickaseプラスミド (m2) | sc-420164-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
MARK3 CRISPR/Cas9 KOプラスミド (h) | sc-406362 | h | Gene Knockout | GFP | 0 | ||
MARK3 CRISPR/Cas9 KOプラスミド (h2) | sc-406362-KO-2 | h | Gene Knockout | GFP | 0 | ||
MARK3 HDRプラスミド (h2) | sc-406362-HDR-2 | h | Homology Directed Repair | Puromycin | 0 | ||
MARK3 Double Nickaseプラスミド (h) | sc-406362-NIC | h | Gene Knockout | Puromycin | 0 | ||
MARK3 Double Nickaseプラスミド (h2) | sc-406362-NIC-2 | h | Gene Knockout | Puromycin | 0 | ||
MARK3 CRISPR/Cas9 KOプラスミド (m) | sc-421560 | m | Gene Knockout | GFP | 0 | ||
MARK3 HDRプラスミド (m) | sc-421560-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
MARK3 Double Nickaseプラスミド (m) | sc-421560-NIC | m | Gene Knockout | Puromycin | 0 | ||
MARK3 Double Nickaseプラスミド (m2) | sc-421560-NIC-2 | m | Gene Knockout | Puromycin | 0 | ||
MARK4 CRISPR/Cas9 KOプラスミド (h) | sc-404386 | h | Gene Knockout | GFP | 1 | ||
MARK4 HDRプラスミド (h) | sc-404386-HDR | h | Homology Directed Repair | Puromycin | 1 | ||
MARK4 Double Nickaseプラスミド (h) | sc-404386-NIC | h | Gene Knockout | Puromycin | 1 | ||
MARK4 Double Nickaseプラスミド (h2) | sc-404386-NIC-2 | h | Gene Knockout | Puromycin | 1 | ||
MARK4 CRISPR/Cas9 KOプラスミド (m) | sc-433214 | m | Gene Knockout | GFP | 0 | ||
MARK4 HDRプラスミド (m) | sc-433214-HDR | m | Homology Directed Repair | Puromycin | 0 | ||
MARK4 Double Nickaseプラスミド (m) | sc-433214-NIC | m | Gene Knockout | Puromycin | 0 | ||
MARK4 Double Nickaseプラスミド (m2) | sc-433214-NIC-2 | m | Gene Knockout | Puromycin | 0 |
MARK CRISPR Activation Products
| Empty Table Header | 製品名 | CATALOG # | Species | アプリケーション | MARKER | 引用文献 | レーティング |
|---|---|---|---|---|---|---|---|
MARK1 CRISPR Activationプラスミド (h) | sc-404508-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK1 CRISPR Activationプラスミド (h2) | sc-404508-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK1 Lentiviral Activation Particles (h) | sc-404508-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK1 Lentiviral Activation Particles (h2) | sc-404508-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK1 CRISPR Activationプラスミド (m) | sc-432657-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK1 CRISPR Activationプラスミド (m2) | sc-432657-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK1 Lentiviral Activation Particles (m) | sc-432657-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK1 Lentiviral Activation Particles (m2) | sc-432657-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK2 CRISPR Activationプラスミド (h) | sc-403714-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
MARK2 CRISPR Activationプラスミド (h2) | sc-403714-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
MARK2 Lentiviral Activation Particles (h) | sc-403714-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
MARK2 Lentiviral Activation Particles (h2) | sc-403714-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
MARK2 CRISPR Activationプラスミド (m) | sc-420164-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK2 CRISPR Activationプラスミド (m2) | sc-420164-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK2 Lentiviral Activation Particles (m) | sc-420164-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK2 Lentiviral Activation Particles (m2) | sc-420164-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK3 CRISPR Activationプラスミド (h) | sc-406362-ACT | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK3 CRISPR Activationプラスミド (h2) | sc-406362-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK3 Lentiviral Activation Particles (h) | sc-406362-LAC | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK3 Lentiviral Activation Particles (h2) | sc-406362-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK3 CRISPR Activationプラスミド (m) | sc-421560-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK3 CRISPR Activationプラスミド (m2) | sc-421560-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK3 Lentiviral Activation Particles (m) | sc-421560-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK3 Lentiviral Activation Particles (m2) | sc-421560-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK4 CRISPR Activationプラスミド (h) | sc-404386-ACT | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
MARK4 CRISPR Activationプラスミド (h2) | sc-404386-ACT-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
MARK4 Lentiviral Activation Particles (h) | sc-404386-LAC | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
MARK4 Lentiviral Activation Particles (h2) | sc-404386-LAC-2 | h | Gene Activation | Puro, Blast, Hygro | 1 | ||
MARK4 CRISPR Activationプラスミド (m) | sc-433214-ACT | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK4 CRISPR Activationプラスミド (m2) | sc-433214-ACT-2 | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK4 Lentiviral Activation Particles (m) | sc-433214-LAC | m | Gene Activation | Puro, Blast, Hygro | 0 | ||
MARK4 Lentiviral Activation Particles (m2) | sc-433214-LAC-2 | m | Gene Activation | Puro, Blast, Hygro | 0 |